Mannava, Sudha <br/><br/>
KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells.  [electronic resource] 

 -  Blood  Feb 2012 
 - 1450-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2011-04-346676  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Indoles<br/>Kruppel-Like Transcription Factors--genetics<br/>Multiple Myeloma--genetics<br/>Oligonucleotide Array Sequence Analysis<br/>Panobinostat<br/>Promoter Regions, Genetic--genetics<br/>Protein Binding<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Pyrazines--pharmacology<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transcription Factors--genetics